Market Research Logo

A Assisted Reproductive Technology Market Size By Procedure (Fresh Donor, Fresh Nondonor, Frozen Donor, Frozen Nondonor, Embryo/Egg Banking), By Technology {In-Vitro Fertilization (IVF) [IVF with Intracytoplasmic Sperm Injection (ICSI), IVF without ICSI]

Assisted Reproductive Technology Market Size By Procedure (Fresh Donor, Fresh Nondonor, Frozen Donor, Frozen Nondonor, Embryo/Egg Banking), By Technology {In-Vitro Fertilization (IVF) [IVF with Intracytoplasmic Sperm Injection (ICSI), IVF without ICSI], Artificial Insemination-Intrauterine Insemination (AI-IUI), Frozen Embryo Replacement (FER)}, By End-Use (Hospitals, Fertility Clinics) Industry Analysis Report, Regional Outlook (U.S., Canada, UK, Germany, France, Spain, Italy, China, India, Japan, Brazil, Mexico, Argentina, South Africa, Saudi Arabia), Technology Potential, Price Trends, Competitive Market Share & Forecast, 2018 - 2024

Assisted Reproductive Technology Market will reach over USD 32.5 billion by 2024; as per a new research report.

Increasing number of people suffering from infertility issues coupled with rising awareness about assisted reproductive technology (ART) will drive ART market over the forecast timeframe. Furthermore, changing social factors and rising disposable income should positively impact industry expansion.

Procedures such as in-vitro fertilization are offered at low cost in developing countries such as India, hence many people having trouble with getting or staying pregnant opt for this treatment in developing countries, leading to business growth. Growing awareness about ART procedure and its success rates will further lead to industry growth during the forecast period.

Delayed child bearing is one of the dominant factors for increasing adoption of assisted reproductive technology. Numerous initiatives such as the Asia Pacific Initiative on Reproduction (ASPIRE), an exclusive task force of scientists and clinicians, engaged in fertility management and ART in the region should support industry growth. However, high cost associated with ART treatment will hamper industry expansion to certain extent over the coming years.

Embryo/egg banking procedure segment is estimated to reach over 5.8 billion by 2024. Embryo banking preserves couple’s reproductive future. Moreover, cryopreserved eggs/embryos can be thawed later and utilized for in-vitro fertilization will drive segment growth. More than 1,000 children are conceived with the help of embryo banking in Southern California alone.

Frozen embryo replacement (FER) technology segment will witness significant growth of 6.1% during the forecast period. FER technology has high success rate as compared to fresh embryo transfer cycles as well as it offers better planning for transfer of embryo. Nearly 85% of embryos survive thawing procedure, reducing need for repetitive procedures. All these factors will drive segment growth during the forecast period.

Hospitals end-use segment accounted for 6.8 billion in 2017. Rising prevalence of infertility problems coupled with growing awareness about assisted reproductive technology and its success rate should drive segment growth during the forecast period. According to CDC data, around fifteen states in the U.S. provide insurance coverage for infertility treatment should positively impact market growth.

Germany assisted reproductive technology market will reach 2.2 billion by 2024, owing to high technology adoption coupled with rising awareness about ART procedures in the country. Delayed child bearing is major driver for assisted reproductive technology market growth in Germany. Growing demand and adoption rate of ART will drive industry growth during the forecast timeframe.

India assisted reproductive technology market will witness lucrative growth rate of 6.9% during the analysis period. High adoption of in-vitro fertilization in the country coupled with low cost of ART procedures should drive Indian ART market during the forecast period. Increasing number of medical facilities such as fertility clinics and several initiatives undertaken to create awareness about assisted reproductive technology should further stimulate business growth over the coming years.

Few notable players operating in global assisted reproductive technology market are Cooper Surgical, Hamilton Thorne, Irvine scientific, Merck and Thermo Fisher Scientific. Industry players are investing heavily in developing cost-effective products to gain competitive edge in lucratively growing markets of developing regions such as Asia Pacific. Companies are adopting strategies such as acquisition and partnership with local players of these regions to consolidate their market position.


Chapter 1. Methodology
1.1. Methodology
1.2. Market definitions
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary
1.4.1.1. Paid sources
1.4.1.2. Unpaid sources
1.4.2. Primary
Chapter 2. Executive Summary
2.1. Assisted reproductive technology industry 360 degree synopsis, 2013 - 2024 (USD Million)
2.1.1. Business trends
2.1.2. Procedure trends
2.1.3. Technology trends
2.1.4. End-use trends
2.1.5. Regional trends
Chapter 3. Assisted Reproductive Technology Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2013 - 2024
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Rising prevalence of infertility
3.3.1.2. Demographical shift
3.3.1.3. Rising awareness about assisted reproductive technology
3.3.2. Industry pitfalls and challenges
3.3.2.1. High cost of procedures
3.3.2.2. Social barriers and lack of advanced infrastructure in emerging countries
3.4. Growth potential analysis
3.4.1. By procedure
3.4.2. By technology
3.4.3. By end-use
3.5. Porter's analysis
3.6. Competitive landscape,2017
3.6.1. Strategy dashboard
3.7. PESTEL analysis
Chapter 4. Assisted Reproductive Technology Market, By Procedure
4.1. Key segment trends
4.2. Fresh donor
4.2.1. Market size, by region, 2013-2024 (USD Million)
4.3. Fresh nondonor
4.3.1. Market size, by region, 2013-2024 (USD Million)
4.4. Frozen donor
4.4.1. Market size, by region, 2013-2024 (USD Million)
4.5. Frozen nondonor
4.5.1. Market size, by region, 2013-2024 (USD Million)
4.6. Embryo/Egg Banking
4.6.1. Market size, by region, 2013-2024 (USD Million)
Chapter 5. Assisted Reproductive Technology Market, By Technology
5.1. Key segment trends
5.2. In-vitro fertilization (IVF)
5.2.1. Market size, by region, 2013-2024 (USD Million)
5.2.2. IVF with Intracytoplasmic Sperm Injection (ICSI)
5.2.2.1. Market size, by region, 2013-2024 (USD Million)
5.2.3. IVF without ICSI
5.2.3.1. Market size, by region, 2013-2024 (USD Million)
5.3. Artificial Insemination - Intrauterine Insemination (AI-IUI)
5.3.1. Market size, by region, 2013-2024 (USD Million)
5.4. Frozen Embryo Replacement (FER)
5.4.1. Market size, by region, 2013-2024 (USD Million)
5.5. Others
5.5.1. Market size, by region, 2013-2024 (USD Million)
Chapter 6. Assisted Reproductive Technology Market, By End-use
6.1. Key segment trends
6.2. Hospitals
6.2.1. Market size, by region, 2013-2024 (USD Million)
6.3. Fertility clinics
6.3.1. Market size, by region, 2013-2024 (USD Million)
6.4. Others
6.4.1. Market size, by region, 2013-2024 (USD Million)
Chapter 7. Assisted Reproductive Technology Market, By Region
7.1. Key regional trends
7.2. North America
7.2.1. Market size, by country, 2013-2024 (USD Mn)
7.2.2. Market size, by procedure, 2013-2024 (USD Million)
7.2.3. Market size, by technology, 2013-2024 (USD Million)
7.2.3.1. Market size, by IVF, 2013-2024 (USD Million)
7.2.4. Market size, by end-use, 2013-2024 (USD Million)
7.2.5. U.S.
7.2.5.1. Market size, by country, 2013-2024 (USD Mn)
7.2.5.2. Market size, by procedure, 2013-2024 (USD Million)
7.2.5.3. Market size, by technology, 2013-2024 (USD Million)
7.2.5.3.1. Market size, by IVF, 2013-2024 (USD Million)
7.2.5.4. Market size, by end-use, 2013-2024 (USD Million)
7.2.6. Canada
7.2.6.1. Market size, by country, 2013-2024 (USD Mn)
7.2.6.2. Market size, by procedure, 2013-2024 (USD Million)
7.2.6.3. Market size, by technology, 2013-2024 (USD Million)
7.2.6.3.1. Market size, by IVF, 2013-2024 (USD Million)
7.2.6.4. Market size, by end-use, 2013-2024 (USD Million)
7.3. Europe
7.3.1. Market size, by country, 2013-2024 (USD Mn)
7.3.2. Market size, by country, 2013-2024 (USD Mn)
7.3.3. Market size, by procedure, 2013-2024 (USD Million)
7.3.4. Market size, by technology, 2013-2024 (USD Million)
7.3.4.1. Market size, by IVF, 2013-2024 (USD Million)
7.3.5. Market size, by end-use, 2013-2024 (USD Million)
7.3.6. Germany
7.3.6.1. Market size, by country, 2013-2024 (USD Mn)
7.3.6.2. Market size, by procedure, 2013-2024 (USD Million)
7.3.6.3. Market size, by technology, 2013-2024 (USD Million)
7.3.6.3.1. Market size, by IVF, 2013-2024 (USD Million)
7.3.6.4. Market size, by end-use, 2013-2024 (USD Million)
7.3.7. UK
7.3.7.1. Market size, by country, 2013-2024 (USD Mn)
7.3.7.2. Market size, by procedure, 2013-2024 (USD Million)
7.3.7.3. Market size, by technology, 2013-2024 (USD Million)
7.3.7.3.1. Market size, by IVF, 2013-2024 (USD Million)
7.3.7.4. Market size, by end-use, 2013-2024 (USD Million)
7.3.8. France
7.3.8.1. Market size, by country, 2013-2024 (USD Mn)
7.3.8.2. Market size, by procedure, 2013-2024 (USD Million)
7.3.8.3. Market size, by technology, 2013-2024 (USD Million)
7.3.8.3.1. Market size, by IVF, 2013-2024 (USD Million)
7.3.8.4. Market size, by end-use, 2013-2024 (USD Million)
7.3.9. Italy
7.3.9.1. Market size, by country, 2013-2024 (USD Mn)
7.3.9.2. Market size, by procedure, 2013-2024 (USD Million)
7.3.9.3. Market size, by technology, 2013-2024 (USD Million)
7.3.9.3.1. Market size, by IVF, 2013-2024 (USD Million)
7.3.9.4. Market size, by end-use, 2013-2024 (USD Million)
7.3.10. Spain
7.3.10.1. Market size, by country, 2013-2024 (USD Mn)
7.3.10.2. Market size, by procedure, 2013-2024 (USD Million)
7.3.10.3. Market size, by technology, 2013-2024 (USD Million)
7.3.10.3.1. Market size, by IVF, 2013-2024 (USD Million)
7.3.10.4. Market size, by end-use, 2013-2024 (USD Million)
7.4. Asia Pacific
7.4.1. Market size, by country, 2013-2024 (USD Mn)
7.4.2. Market size, by country, 2013-2024 (USD Mn)
7.4.3. Market size, by procedure, 2013-2024 (USD Million)
7.4.4. Market size, by technology, 2013-2024 (USD Million)
7.4.4.1. Market size, by IVF, 2013-2024 (USD Million)
7.4.5. Market size, by end-use, 2013-2024 (USD Million)
7.4.6. China
7.4.6.1. Market size, by country, 2013-2024 (USD Mn)
7.4.6.2. Market size, by procedure, 2013-2024 (USD Million)
7.4.6.3. Market size, by technology, 2013-2024 (USD Million)
7.4.6.3.1. Market size, by IVF, 2013-2024 (USD Million)
7.4.6.4. Market size, by end-use, 2013-2024 (USD Million)
7.4.7. Japan
7.4.7.1. Market size, by country, 2013-2024 (USD Mn)
7.4.7.2. Market size, by procedure, 2013-2024 (USD Million)
7.4.7.3. Market size, by technology, 2013-2024 (USD Million)
7.4.7.3.1. Market size, by IVF, 2013-2024 (USD Million)
7.4.7.4. Market size, by end-use, 2013-2024 (USD Million)
7.4.8. India
7.4.8.1. Market size, by country, 2013-2024 (USD Mn)
7.4.8.2. Market size, by procedure, 2013-2024 (USD Million)
7.4.8.3. Market size, by technology, 2013-2024 (USD Million)
7.4.8.3.1. Market size, by IVF, 2013-2024 (USD Million)
7.4.8.4. Market size, by end-use, 2013-2024 (USD Million)
7.5. Latin America
7.5.1. Market size, by country, 2013-2024 (USD Mn)
7.5.2. Market size, by country, 2013-2024 (USD Mn)
7.5.3. Market size, by procedure, 2013-2024 (USD Million)
7.5.4. Market size, by technology, 2013-2024 (USD Million)
7.5.4.1. Market size, by IVF, 2013-2024 (USD Million)
7.5.5. Market size, by end-use, 2013-2024 (USD Million)
7.5.6. Brazil
7.5.6.1. Market size, by country, 2013-2024 (USD Mn)
7.5.6.2. Market size, by procedure, 2013-2024 (USD Million)
7.5.6.3. Market size, by technology, 2013-2024 (USD Million)
7.5.6.3.1. Market size, by IVF, 2013-2024 (USD Million)
7.5.6.4. Market size, by end-use, 2013-2024 (USD Million)
7.5.7. Mexico
7.5.7.1. Market size, by country, 2013-2024 (USD Mn)
7.5.7.2. Market size, by procedure, 2013-2024 (USD Million)
7.5.7.3. Market size, by technology, 2013-2024 (USD Million)
7.5.7.3.1. Market size, by IVF, 2013-2024 (USD Million)
7.5.7.4. Market size, by end-use, 2013-2024 (USD Million)
7.5.8. Argentina
7.6. MEA
7.6.1. Market size, by country, 2013-2024 (USD Mn)
7.6.2. Market size, by country, 2013-2024 (USD Mn)
7.6.3. Market size, by procedure, 2013-2024 (USD Million)
7.6.4. Market size, by technology, 2013-2024 (USD Million)
7.6.4.1. Market size, by IVF, 2013-2024 (USD Million)
7.6.5. Market size, by end-use, 2013-2024 (USD Million)
7.6.6. South Africa
7.6.6.1. Market size, by country, 2013-2024 (USD Mn)
7.6.6.2. Market size, by procedure, 2013-2024 (USD Million)
7.6.6.3. Market size, by technology, 2013-2024 (USD Million)
7.6.6.3.1. Market size, by IVF, 2013-2024 (USD Million)
7.6.6.4. Market size, by end-use, 2013-2024 (USD Million)
7.6.7. Saudi Arabia
7.6.7.1. Market size, by country, 2013-2024 (USD Mn)
7.6.7.2. Market size, by procedure, 2013-2024 (USD Million)
7.6.7.3. Market size, by technology, 2013-2024 (USD Million)
7.6.7.3.1. Market size, by IVF, 2013-2024 (USD Million)
7.6.7.4. Market size, by end-use, 2013-2024 (USD Million)
Chapter 8. Company Profiles
8.1. Cooper Surgical Inc.
8.1.1. Business overview
8.1.2. Financial data
8.1.3. Product landscape
8.1.4. Strategic outlook
8.1.5. SWOT analysis
8.2. Cook Medical
8.2.1. Business overview
8.2.2. Financial data
8.2.3. Product landscape
8.2.4. Strategic outlook
8.2.5. SWOT analysis
8.3. Genea Limited
8.3.1. Business overview
8.3.2. Financial data
8.3.3. Product landscape
8.3.4. Strategic outlook
8.3.5. SWOT analysis
8.4. Hamilton Thorne
8.4.1. Business overview
8.4.2. Financial data
8.4.3. Product landscape
8.4.4. Strategic outlook
8.4.5. SWOT analysis
8.5. IVFtech ApS
8.5.1. Business overview
8.5.2. Financial data
8.5.3. Product landscape
8.5.4. Strategic outlook
8.5.5. SWOT analysis
8.6. Irvine scientific
8.6.1. Business overview
8.6.2. Financial data
8.6.3. Product landscape
8.6.4. Strategic outlook
8.6.5. SWOT analysis
8.7. Merck
8.7.1. Business overview
8.7.2. Financial data
8.7.3. Product landscape
8.7.4. Strategic outlook
8.7.5. SWOT analysis
8.8. Nidacon International AB
8.8.1. Business overview
8.8.2. Financial data
8.8.3. Product landscape
8.8.4. Strategic outlook
8.8.5. SWOT analysis
8.9. OvaScience Inc.
8.9.1. Business overview
8.9.2. Financial data
8.9.3. Product landscape
8.9.4. Strategic outlook
8.9.5. SWOT analysis
8.10. Thermo Fisher Scientific, Inc.
8.10.1. Business overview
8.10.2. Financial data
8.10.3. Product landscape
8.10.4. Strategic outlook
8.10.5. SWOT analysis
8.11. Vitro Life
8.11.1. Business overview
8.11.2. Financial data
8.11.3. Product landscape
8.11.4. Strategic outlook
8.11.5. SWOT analysis
Data Tables/B>
TABLE 1. Assisted reproductive technology industry 360 degree synopsis, 2013 - 2024
TABLE 2. Global assisted reproductive technology market, 2013 - 2017 (USD Million)
TABLE 3. Global assisted reproductive technology market, 2018 - 2024 (USD Million)
TABLE 4. Global assisted reproductive technology market, by procedure, 2013 - 2017 (USD Million)
TABLE 5. Global assisted reproductive technology market, by procedure, 2018 - 2024 (USD Million)
TABLE 6. Global assisted reproductive technology market, by technology, 2013 - 2017 (USD Million)
TABLE 7. Global assisted reproductive technology market, by technology, 2018 - 2024 (USD Million)
TABLE 8. Global assisted reproductive technology market, by end-use, 2013 - 2017 (USD Million)
TABLE 9. Global assisted reproductive technology market, by end-use, 2018 - 2024 (USD Million)
TABLE 10. Global assisted reproductive technology market, by region, 2013 - 2017 (USD Million)
TABLE 11. Global assisted reproductive technology market, by region, 2018 - 2024 (USD Million)
TABLE 12. Industry impact forces
TABLE 13. Fresh donor market size, by region, 2013 - 2017 (USD Million)
TABLE 14. Fresh donor market size, by region, 2018 - 2024 (USD Million)
TABLE 15. Fresh nondonor market size, by region, 2013 - 2017 (USD Mn)
TABLE 16. Fresh nondonor market size, by region, 2018 - 2024 (USD Mn)
TABLE 17. Frozen donor market size, by region, 2013 - 2017 (USD Million)
TABLE 18. Frozen donor market size, by region, 2018 - 2024 (USD Million)
TABLE 19. Frozen nondonor market size, by region, 2013 - 2017 (USD Mn)
TABLE 20. Frozen nondonor market size, by region, 2018 - 2024 (USD Mn)
TABLE 21. Embryo/Egg banking market size, by region, 2013 - 2017 (USD Mn)
TABLE 22. Embryo/Egg banking market size, by region, 2018 - 2024 (USD Mn)
TABLE 23. In-vitro fertilization (IVF) market size, by region, 2013 - 2017 (USD Million)
TABLE 24. In-vitro fertilization (IVF) market size, by region, 2018 - 2024 (USD Million)
TABLE 25. IVF with ICSI market size, by region, 2013 - 2017 (USD Million)
TABLE 26. IVF with ICSI market size, by region, 2018 - 2024 (USD Million)
TABLE 27. IVF without ICSI market size, by region, 2013 - 2017 (USD Million)
TABLE 28. IVF without ICSI market size, by region, 2018 - 2024 (USD Million)
TABLE 29. Artificial insemination/intrauterine insemination (AI-IUI) market size, by region, 2013 - 2017 (USD Million)
TABLE 30. Artificial insemination/intrauterine insemination (AI-IUI) market size, by region, 2018 - 2024 (USD Million)
TABLE 31. Frozen embryo replacement (FER)market size, by region, 2013 - 2017 (USD Million)
TABLE 32. Frozen embryo replacement (FER)market size, by region, 2018 - 2024 (USD Million)
TABLE 33. Others market size, by region, 2013 - 2017 (USD Million)
TABLE 34. Others market size, by region, 2018 - 2024 (USD Million)
TABLE 35. Hospitals market size, by region, 2013 - 2017 (USD Million)
TABLE 36. Hospitals market size, by region, 2018 - 2024 (USD Million)
TABLE 37. Fertility clinics market size, by region, 2013 - 2017 (USD Million)
TABLE 38. Fertility clinics market size, by region, 2018 - 2024 (USD Million)
TABLE 39. Others market size, by region, 2013 - 2017 (USD Million)
TABLE 40. Others market size, by region, 2018 - 2024 (USD Million)
TABLE 41. North America market, by country, 2013 - 2017 (USD Mn)
TABLE 42. North America market, by country, 2018 - 2024 (USD Mn)
TABLE 43. North America ART market, by procedure, 2013 - 2017 (USD Mn)
TABLE 44. North America ART market, by procedure, 2018 - 2024 (USD Mn)
TABLE 45. North America ART market, by technology, 2013 - 2017 (USD Mn)
TABLE 46. North America ART market, by technology, 2018 - 2024 (USD Mn)
TABLE 47. North America ART market, by IVF, 2013 - 2017 (USD Mn)
TABLE 48. North America ART market, by IVF, 2018 - 2024 (USD Mn)
TABLE 49. North America ART market, by end-use, 2013 - 2017 (USD Mn)
TABLE 50. North America ART market, by end-use, 2018 - 2024 (USD Mn)
TABLE 51. U.S. ART market, by procedure, 2013 - 2017 (USD Mn)
TABLE 52. U.S. ART market, by procedure, 2018 - 2024 (USD Mn)
TABLE 53. U.S. ART market, by technology, 2013 - 2017 (USD Mn)
TABLE 54. U.S. ART market, by technology, 2018 - 2024 (USD Mn)
TABLE 55. U.S. ART market, by IVF, 2013 - 2017 (USD Mn)
TABLE 56. U.S. ART market, by IVF, 2018 - 2024 (USD Mn)
TABLE 57. U.S. ART market, by end-use, 2013 - 2017 (USD Mn)
TABLE 58. U.S. ART market, by end-use, 2018 - 2024 (USD Mn)
TABLE 59. Canada ART market, by procedure, 2013 - 2017 (USD Mn)
TABLE 60. Canada ART market, by procedure, 2018 - 2024 (USD Mn)
TABLE 61. Canada ART market, by technology, 2013 - 2017 (USD Mn)
TABLE 62. Canada ART market, by technology, 2018 - 2024 (USD Mn)
TABLE 63. Canada ART market, by IVF, 2013 - 2017 (USD Mn)
TABLE 64. Canada ART market, by IVF, 2018 - 2024 (USD Mn)
TABLE 65. Canada ART market, by end-use, 2013 - 2017 (USD Mn)
TABLE 66. Canada ART market, by end-use, 2018 - 2024 (USD Mn)
TABLE 67. Europe market, by country, 2013 - 2017 (USD Mn)
TABLE 68. Europe market, by country, 2018 - 2024 (USD Mn)
TABLE 69. Europe ART market, by procedure, 2013 - 2017 (USD Mn)
TABLE 70. Europe ART market, by procedure, 2018 - 2024 (USD Mn)
TABLE 71. Europe ART market, by technology, 2013 - 2017 (USD Mn)
TABLE 72. Europe ART market, by technology, 2018 - 2024 (USD Mn)
TABLE 73. Europe ART market, by IVF, 2013 - 2017 (USD Mn)
TABLE 74. Europe ART market, by IVF, 2018 - 2024 (USD Mn)
TABLE 75. Europe ART market, by end-use, 2013 - 2017 (USD Mn)
TABLE 76. Europe ART market, by end-use, 2018 - 2024 (USD Mn)
TABLE 77. Germany ART market, by procedure, 2013 - 2017 (USD Mn)
TABLE 78. Germany ART market, by procedure, 2018 - 2024 (USD Mn)
TABLE 79. Germany ART market, by technology, 2013 - 2017 (USD Mn)
TABLE 80. Germany ART market, by technology, 2018 - 2024 (USD Mn)
TABLE 81. Germany ART market, by IVF, 2013 - 2017 (USD Mn)
TABLE 82. Germany ART market, by IVF, 2018 - 2024 (USD Mn)
TABLE 83. Germany ART market, by end-use, 2013 - 2017 (USD Mn)
TABLE 84. Germany ART market, by end-use, 2018 - 2024 (USD Mn)
TABLE 85. UK ART market, by procedure, 2013 - 2017 (USD Mn)
TABLE 86. UK ART market, by procedure, 2018 - 2024 (USD Mn)
TABLE 87. UK ART market, by technology, 2013 - 2017 (USD Mn)
TABLE 88. UK ART market, by technology, 2018 - 2024 (USD Mn)
TABLE 89. UK ART market, by IVF, 2013 - 2017 (USD Mn)
TABLE 90. UK ART market, by IVF, 2018 - 2024 (USD Mn)
TABLE 91. UK ART market, by end-use, 2013 - 2017 (USD Mn)
TABLE 92. UK ART market, by end-use, 2018 - 2024 (USD Mn)
TABLE 93. France ART market, by procedure, 2013 - 2017 (USD Mn)
TABLE 94. France ART market, by procedure, 2018 - 2024 (USD Mn)
TABLE 95. France ART market, by technology, 2013 - 2017 (USD Mn)
TABLE 96. France ART market, by technology, 2018 - 2024 (USD Mn)
TABLE 97. France ART market, by IVF, 2013 - 2017 (USD Mn)
TABLE 98. France ART market, by IVF, 2018 - 2024 (USD Mn)
TABLE 99. France ART market, by end-use, 2013 - 2017 (USD Mn)
TABLE 100. France ART market, by end-use, 2018 - 2024 (USD Mn)
TABLE 101. Spain ART market, by procedure, 2013 - 2017 (USD Mn)
TABLE 102. Spain ART market, by procedure, 2018 - 2024 (USD Mn)
TABLE 103. Spain ART market, by technology, 2013 - 2017 (USD Mn)
TABLE 104. Spain ART market, by technology, 2018 - 2024 (USD Mn)
TABLE 105. Spain ART market, by IVF, 2013 - 2017 (USD Mn)
TABLE 106. Spain ART market, by IVF, 2018 - 2024 (USD Mn)
TABLE 107. Spain ART market, by end-use, 2013 - 2017 (USD Mn)
TABLE 108. Spain ART market, by end-use, 2018 - 2024 (USD Mn)
TABLE 109. Italy ART market, by procedure, 2013 - 2017 (USD Mn)
TABLE 110. Italy ART market, by procedure, 2018 - 2024 (USD Mn)
TABLE 111. Italy ART market, by technology, 2013 - 2017 (USD Mn)
TABLE 112. Italy ART market, by technology, 2018 - 2024 (USD Mn)
TABLE 113. Italy ART market, by IVF, 2013 - 2017 (USD Mn)
TABLE 114. Italy ART market, by IVF, 2018 - 2024 (USD Mn)
TABLE 115. Italy ART market, by end-use, 2013 - 2017 (USD Mn)
TABLE 116. Italy ART market, by end-use, 2018 - 2024 (USD Mn)
TABLE 117. Asia Pacific market size, by country, 2013 - 2017 (USD Mn)
TABLE 118. Asia Pacific market size, by country, 2018 - 2024 (USD Mn)
TABLE 119. Asia Pacific ART market, by procedure, 2013 - 2017 (USD Mn)
TABLE 120. Asia Pacific ART market, by procedure, 2018 - 2024 (USD Mn)
TABLE 121. Asia Pacific ART market, by technology, 2013 - 2017 (USD Mn)
TABLE 122. Asia Pacific ART market, by technology, 2018 - 2024 (USD Mn)
TABLE 123. Asia Pacific ART market, by IVF, 2013 - 2017 (USD Mn)
TABLE 124. Asia Pacific ART market, by IVF, 2018 - 2024 (USD Mn)
TABLE 125. Asia Pacific ART market, by end-use, 2013 - 2017 (USD Mn)
TABLE 126. Asia Pacific ART market, by end-use, 2018 - 2024 (USD Mn)
TABLE 127. China ART market, by procedure, 2013 - 2017 (USD Mn)
TABLE 128. China ART market, by procedure, 2018 - 2024 (USD Mn)
TABLE 129. China ART market, by technology, 2013 - 2017 (USD Mn)
TABLE 130. China ART market, by technology, 2018 - 2024 (USD Mn)
TABLE 131. China ART market, by IVF, 2013 - 2017 (USD Mn)
TABLE 132. China ART market, by IVF, 2018 - 2024 (USD Mn)
TABLE 133. China ART market, by end-use, 2013 - 2017 (USD Mn)
TABLE 134. China ART market, by end-use, 2018 - 2024 (USD Mn)
TABLE 135. Japan ART market, by procedure, 2013 - 2017 (USD Mn)
TABLE 136. Japan ART market, by procedure, 2018 - 2024 (USD Mn)
TABLE 137. Japan ART market, by technology, 2013 - 2017 (USD Mn)
TABLE 138. Japan ART market, by technology, 2018 - 2024 (USD Mn)
TABLE 139. Japan ART market, by IVF, 2013 - 2017 (USD Mn)
TABLE 140. Japan ART market, by IVF, 2018 - 2024 (USD Mn)
TABLE 141. Japan ART market, by end-use, 2013 - 2017 (USD Mn)
TABLE 142. Japan ART market, by end-use, 2018 - 2024 (USD Mn)
TABLE 143. India ART market, by procedure, 2013 - 2017 (USD Mn)
TABLE 144. India ART market, by procedure, 2018 - 2024 (USD Mn)
TABLE 145. India ART market, by technology, 2013 - 2017 (USD Mn)
TABLE 146. India ART market, by technology, 2018 - 2024 (USD Mn)
TABLE 147. India ART market, by IVF, 2013 - 2017 (USD Mn)
TABLE 148. India ART market, by IVF, 2018 - 2024 (USD Mn)
TABLE 149. India ART market, by end-use, 2013 - 2017 (USD Mn)
TABLE 150. India ART market, by end-use, 2018 - 2024 (USD Mn)
TABLE 151. Latin America market size, by country, 2013 - 2017 (USD Mn)
TABLE 152. Latin America market size, by country, 2018 - 2024 (USD Mn)
TABLE 153. Latin America ART market, by procedure, 2013 - 2017 (USD Mn)
TABLE 154. Latin America ART market, by procedure, 2018 - 2024 (USD Mn)
TABLE 155. Latin America ART market, by technology, 2013 - 2017 (USD Mn)
TABLE 156. Latin America ART market, by technology, 2018 - 2024 (USD Mn)
TABLE 157. Latin America ART market, by IVF, 2013 - 2017 (USD Mn)
TABLE 158. Latin America ART market, by IVF, 2018 - 2024 (USD Mn)
TABLE 159. Latin America ART market, by end-use, 2013 - 2017 (USD Mn)
TABLE 160. Latin America ART market, by end-use, 2018 - 2024 (USD Mn)
TABLE 161. Brazil ART market, by procedure, 2013 - 2017 (USD Mn)
TABLE 162. Brazil ART market, by procedure, 2018 - 2024 (USD Mn)
TABLE 163. Brazil ART market, by technology, 2013 - 2017 (USD Mn)
TABLE 164. Brazil ART market, by technology, 2018 - 2024 (USD Mn)
TABLE 165. Brazil ART market, by IVF, 2013 - 2017 (USD Mn)
TABLE 166. Brazil ART market, by IVF, 2018 - 2024 (USD Mn)
TABLE 167. Brazil ART market, by end-use, 2013 - 2017 (USD Mn)
TABLE 168. Brazil ART market, by end-use, 2018 - 2024 (USD Mn)
TABLE 169. Mexico ART market, by procedure, 2013 - 2017 (USD Mn)
TABLE 170. Mexico ART market, by procedure, 2018 - 2024 (USD Mn)
TABLE 171. Mexico ART market, by technology, 2013 - 2017 (USD Mn)
TABLE 172. Mexico ART market, by technology, 2018 - 2024 (USD Mn)
TABLE 173. Mexico ART market, by IVF, 2013 - 2017 (USD Mn)
TABLE 174. Mexico ART market, by IVF, 2018 - 2024 (USD Mn)
TABLE 175. Mexico ART market, by end-use, 2013 - 2017 (USD Mn)
TABLE 176. Mexico ART market, by end-use, 2018 - 2024 (USD Mn)
TABLE 177. Argentina ART market, by procedure, 2013 - 2017 (USD Mn)
TABLE 178. Argentina ART market, by procedure, 2018 - 2024 (USD Mn)
TABLE 179. Argentina ART market, by technology, 2013 - 2017 (USD Mn)
TABLE 180. Argentina ART market, by technology, 2018 - 2024 (USD Mn)
TABLE 181. Argentina ART market, by IVF, 2013 - 2017 (USD Mn)
TABLE 182. Argentina ART market, by IVF, 2018 - 2024 (USD Mn)
TABLE 183. Argentina ART market, by end-use, 2013 - 2017 (USD Mn)
TABLE 184. Argentina ART market, by end-use, 2018 - 2024 (USD Mn)
TABLE 185. MEA market size, by country, 2013 - 2017 (USD Million)
TABLE 186. MEA market size, by country, 2018 - 2024 (USD Million)
TABLE 187. MEA ART market, by procedure, 2013 - 2017 (USD Mn)
TABLE 188. MEA ART market, by procedure, 2018 - 2024 (USD Mn)
TABLE 189. MEA ART market, by technology, 2013 - 2017 (USD Mn)
TABLE 190. MEA ART market, by technology, 2018 - 2024 (USD Mn)
TABLE 191. MEA ART market, by IVF, 2013 - 2017 (USD Mn)
TABLE 192. MEA ART market, by IVF, 2018 - 2024 (USD Mn)
TABLE 193. MEA ART market, by end-use, 2013 - 2017 (USD Mn)
TABLE 194. MEA ART market, by end-use, 2018 - 2024 (USD Mn)
TABLE 195. South Africa ART market, by procedure, 2013 - 2017 (USD Mn)
TABLE 196. South Africa ART market, by procedure, 2018 - 2024 (USD Mn)
TABLE 197. South Africa ART market, by technology, 2013 - 2017 (USD Mn)
TABLE 198. South Africa ART market, by technology, 2018 - 2024 (USD Mn)
TABLE 199. South Africa ART market, by IVF, 2013 - 2017 (USD Mn)
TABLE 200. South Africa ART market, by IVF, 2018 - 2024 (USD Mn)
TABLE 201. South Africa ART market, by end-use, 2013 - 2017 (USD Mn)
TABLE 202. South Africa ART market, by end-use, 2018 - 2024 (USD Mn)
TABLE 203. Saudi Arabia ART market, by procedure, 2013 - 2017 (USD Mn)
TABLE 204. Saudi Arabia ART market, by procedure, 2018 - 2024 (USD Mn)
TABLE 205. Saudi Arabia ART market, by technology, 2013 - 2017 (USD Mn)
TABLE 206. Saudi Arabia ART market, by technology, 2018 - 2024 (USD Mn)
TABLE 207. Saudi Arabia ART market, by IVF, 2013 - 2017 (USD Mn)
TABLE 208. Saudi Arabia ART market, by IVF, 2018 - 2024 (USD Mn)
TABLE 209. Saudi Arabia ART market, by end-use, 2013 - 2017 (USD Mn)
TABLE 210. Saudi Arabia ART market, by end-use, 2018 - 2024 (USD Mn)
Charts & Figures
FIG 1. Industry segmentation
FIG 2. Global assisted reproductive technology (ART) market, 2013 - 2024
FIG 3. Growth potential analysis, by procedure
FIG 4. Growth potential analysis, by technology
FIG 5. Growth potential analysis, by end-use
FIG 6. Porter's analysis
FIG 7. Strategy dashboard
FIG 8. PESTEL analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report